Hakutulokset - Angela Panoskaltsis‐Mortari
- Näytetään 1 - 20 yhteensä 100 tuloksesta
- Siirry seuraavalle sivulle
-
1
3D bioprinting for lungs and hollow organs Tekijä Zachary Galliger, Caleb Vogt, Angela Panoskaltsis‐Mortari
Julkaistu 2019Revisão -
2
Leukocyte migration and graft-versus-host disease Tekijä Christian Wysocki, Angela Panoskaltsis‐Mortari, Bruce R. Blazar, Jonathan S. Serody
Julkaistu 2005Revisão -
3
Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility co... Tekijä BR Blazar, PA Taylor, Angela Panoskaltsis‐Mortari, GS Gray, DA Vallera
Julkaistu 1995Artigo -
4
-
5
-
6
Rapamycin Inhibits the Generation of Graft-Versus-Host Disease- and Graft-Versus-Leukemia-Causing T Cells by Interfering with the Production of Th1 or Th1 Cytotoxic Cytokines Tekijä Bruce R. Blazar, Patricia A. Taylor, Angela Panoskaltsis‐Mortari, Daniel A. Vallera
Julkaistu 1998Artigo -
7
-
8
Genetic alteration of a bispecific ligand-directed toxin targeting human CD19 and CD22 receptors resulting in improved efficacy against systemic B cell malignancy Tekijä Daniel A. Vallera, Hua Chen, Andrew R. Sicheneder, Angela Panoskaltsis‐Mortari, Elizabeth Taras
Julkaistu 2009Artigo -
9
-
10
-
11
-
12
In vitro–differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations Tekijä Michael Carlson, Michelle L. West, James M. Coghill, Angela Panoskaltsis‐Mortari, Bruce R. Blazar, Jonathan S. Serody
Julkaistu 2008Artigo -
13
Ligation of 4-1BB (CDw137) Regulates Graft-Versus-Host Disease, Graft-Versus-Leukemia, and Graft Rejection in Allogeneic Bone Marrow Transplant Recipients Tekijä Bruce R. Blazar, Byoung S. Kwon, Angela Panoskaltsis‐Mortari, Kyu B. Kwak, Jacques J. Peschon, Patricia A. Taylor
Julkaistu 2001Artigo -
14
-
15
-
16
Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethality Tekijä Lisa K. Jasperson, Christoph Bucher, Angela Panoskaltsis‐Mortari, Andrew L. Mellor, David H. Munn, Bruce R. Blazar
Julkaistu 2009Artigo -
17
CD28/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-bone marrow transplantation splenocyte infusion in murine recipients of myeloid or... Tekijä Bruce R. Blazar, Patricia A. Taylor, Michael W. Boyer, Angela Panoskaltsis‐Mortari, James P. Allison, Daniel A. Vallera
Julkaistu 1997Artigo -
18
-
19
Infusion of anti-B7.1 (CD80) and anti-B7.2 (CD86) monoclonal antibodies inhibits murine graft-versus-host disease lethality in part via direct effects on CD4+ and CD8+ T cells. Tekijä Bruce R. Blazar, Arlene H. Sharpe, Patricia A. Taylor, Angela Panoskaltsis‐Mortari, G S Gray, Robert Korngold, Daniel A. Vallera
Julkaistu 1996Artigo -
20
Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients Tekijä Patricia A. Taylor, Michael Ehrhardt, Matthew M. Roforth, Jessica M. Swedin, Angela Panoskaltsis‐Mortari, Jonathan S. Serody, Bruce R. Blazar
Julkaistu 2006Artigo
Työkalut:
Liittyvät aiheet
Immunology
Biology
Medicine
Internal medicine
Immune system
Graft-versus-host disease
Cancer research
Biochemistry
T cell
Cell biology
Transplantation
In vitro
Stem cell
Genetics
Cytotoxic T cell
Pathology
Receptor
Disease
CD8
Bone marrow
Lung
Antibody
Antigen
Chemistry
Leukemia
Cytokine
Gene
Chemotherapy
Inflammation
Adoptive cell transfer